5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.49▼ | 2.49▲ | 2.48▲ | 2.58▼ | 2.61▼ |
MA10 | 2.49▼ | 2.47▲ | 2.48▲ | 2.58▼ | 2.81▼ |
MA20 | 2.49▲ | 2.49▲ | 2.54▼ | 2.66▼ | 2.93▼ |
MA50 | 2.47▲ | 2.56▼ | 2.62▼ | 2.87▼ | 4.13▼ |
MA100 | 2.49▲ | 2.61▼ | 2.61▼ | 3.01▼ | 3.94▼ |
MA200 | 2.54▼ | 2.60▼ | 2.73▼ | 3.71▼ | 4.78▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.007▲ | -0.002▼ | -0.001▼ | -0.007▼ |
RSI | 54.658▲ | 44.602▼ | 39.727▼ | 43.158▼ | 39.971▼ |
STOCH | 51.389 | 76.487 | 35.017 | 35.040 | 15.979▼ |
WILL %R | -60.000 | -17.647▲ | -62.162 | -80.153▼ | -91.671▼ |
CCI | 48.276 | 117.091▲ | -26.248 | -83.640 | -101.576▼ |
▼ MACD | $IBRX MACD(12,26,9) Crossed Below Signal Line | Set Alert |
Tuesday, April 29, 2025 09:50 AM
ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of Anktiva despite short-term IBRX challenges.
|
Sunday, April 20, 2025 05:00 PM
CULVER CITY, Calif., April 28, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced positive long-term results from its QUILT-3.032 study of ANKTIVA ...
|
Wednesday, April 16, 2025 09:05 PM
The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened by Federal Chairman Jerome Powell’s bearish comments on the US economy, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/04/25 | 2.45 | 2.51 | 2.4101 | 2.51 | 3,470,591 |
29/04/25 | 2.595 | 2.605 | 2.485 | 2.485 | 4,041,879 |
28/04/25 | 2.65 | 2.78 | 2.58 | 2.63 | 3,701,124 |
25/04/25 | 2.67 | 2.67 | 2.55 | 2.61 | 3,296,891 |
24/04/25 | 2.70 | 2.73 | 2.63 | 2.69 | 3,360,030 |
23/04/25 | 2.80 | 2.87 | 2.68 | 2.69 | 5,650,891 |
22/04/25 | 2.54 | 2.75 | 2.54 | 2.69 | 6,178,131 |
21/04/25 | 2.45 | 2.58 | 2.405 | 2.51 | 4,701,258 |
17/04/25 | 2.47 | 2.50 | 2.39 | 2.47 | 4,706,743 |
16/04/25 | 2.73 | 2.75 | 2.39 | 2.48 | 8,278,056 |
|
|
||||
|
|
||||
|
|